about
Interaction of tumor cells with the microenvironmentSilencing of the transforming growth factor-beta (TGFbeta) receptor II by Kruppel-like factor 14 underscores the importance of a negative feedback mechanism in TGFbeta signalingClinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathwayMembrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis?Pancreatic ductal and acinar cell neoplasms in Carney complex: a possible new associationGatifloxacin induces S and G2-phase cell cycle arrest in pancreatic cancer cells via p21/p27/p53Mathematical modeling of Interleukin-35 promoting tumor growth and angiogenesisNovel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinomaZebrafish reporter lines reveal in vivo signaling pathway activities involved in pancreatic cancer.Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.RBBP9: a tumor-associated serine hydrolase activity required for pancreatic neoplasia.Utilizing somatic mutation data from numerous studies for cancer research: proof of concept and applications.Homotypic cell cannibalism, a cell-death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer.Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft modelsPDX-1: demonstration of oncogenic properties in pancreatic cancer.Expression profiles of SnoN in normal and cancerous human tissues support its tumor suppressor role in human cancer.The influence of SnoN gene silencing by siRNA on the cell proliferation and apoptosis of human pancreatic cancer cells.In Vivo Senescence in the Sbds-Deficient Murine Pancreas: Cell-Type Specific Consequences of Translation Insufficiency.Aberrant signaling pathways in pancreatic cancer: a two compartment view.TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer CachexiaResponse gene to complement-32 enhances metastatic phenotype by mediating transforming growth factor beta-induced epithelial-mesenchymal transition in human pancreatic cancer cell line BxPC-3Transforming growth factor β-induced epithelial-mesenchymal transition increases cancer stem-like cells in the PANC-1 cell line.TGF-beta and tumors--an ill-fated alliance.Differentiating Branch Duct and Mixed IPMN in Endoscopically Collected Pancreatic Cyst Fluid via Cytokine AnalysisTGFβ receptor signaling is essential for inflammation-induced but not β-cell workload-induced β-cell proliferationA Novel Mechanism of PPARgamma Regulation of TGFbeta1: Implication in Cancer BiologyNordihydroguaiaretic acid inhibits transforming growth factor beta type 1 receptor activity and downstream signaling.Emerging drugs in the treatment of pancreatic cancer.Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.An overview of genetic polymorphisms and pancreatic cancer risk in molecular epidemiologic studies.Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas.Oxidative Stress: A New Target for Pancreatic Cancer Prognosis and Treatment.PAR-4 as a possible new target for pancreatic cancer therapy.Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer.Emerging pathways and future targets for the molecular therapy of pancreatic cancer.PAR-4: a possible new target for age-related disease.Targeting the microenvironment of pancreatic cancer: overcoming treatment barriers and improving local immune responses.Inhibition of S-Adenosylmethionine-Dependent Methyltransferase Attenuates TGFβ1-Induced EMT and Metastasis in Pancreatic Cancer: Putative Roles of miR-663a and miR-4787-5p.TGF-β signaling in liver and gastrointestinal cancersAugmented TGFβ receptor signaling induces apoptosis of pancreatic carcinoma cells.
P2860
Q21245506-200D6567-7967-4672-B9C3-613735C85262Q24647149-6136CA67-2BEF-403E-8C39-85CBBAFC342DQ26797238-87C51C67-1C93-4B49-BF1E-C25941C42F5BQ28084572-D12A33FA-7C1C-419F-93B0-2BFDA81F61EEQ28247409-E3C2F848-66FF-4DD9-8675-47C9B72BD051Q28484635-F9F07D14-CCB4-41A9-A247-851BE595B4F8Q28544606-73C6A250-C93D-4AB6-AB51-ED30AE278CADQ30360377-082142E1-1323-41DB-9B5D-78CFF5ABD0CDQ30581795-F872B1EC-593D-4D6E-B201-0B5A6F45E344Q33592374-15E2968C-456D-4BF2-9135-60F9F6151C9FQ33719861-74AC42C6-4B9E-4C8E-AD97-1366FF37A913Q33835909-DD1F8BE8-3380-4156-8ED6-5C1E9DF197DBQ34032893-5B79F09D-E9D6-445A-8F9C-AA5EE55B559EQ34201623-D5FF6794-62B1-4E7E-9023-9B7A539FFFD2Q34474763-023FF59D-5DDE-44F3-9454-AB31F916E0B2Q34589591-71C38FDC-3A3F-4391-8943-46BDEF7D244CQ35532374-A5B62CF0-EBA1-4133-BF8A-A31D17A2AF48Q35658181-8BAAEE97-4809-4BB3-B890-AF31B698A80DQ35660658-771F50F4-9898-4628-92D0-6D8B88221057Q35690582-6401064F-F822-4138-92B2-1C47BD6C02DDQ35914358-087FF38A-F1F5-4295-A317-D94461ED4365Q35995569-2A023D21-1B75-446A-92B1-FBE7642DE7EBQ36020084-7E8D0AD6-508A-4B98-B317-136EB129B90EQ36528451-F69D434F-8C72-4270-A738-6C648A2825DFQ36720507-DDDFF2F9-D951-4BEE-A00D-735440B0FC43Q36743890-D78C3463-14E8-4F5F-9831-5B39D06735B2Q37342557-186BA8E1-FDAA-46AB-8E59-54EDE74F195FQ37494647-CF5C95C9-6714-408A-A968-C7775E6904F0Q37495918-1145E800-CA4E-44DC-9666-E047362487A7Q37506586-AC0DCA17-E0BC-4AC7-9472-B474212423B0Q37649636-95BF4378-58D3-4A56-943E-E1B53F261A36Q37729938-D352D33C-F8DE-4D32-9ABC-8E1BAA3757BEQ37738894-6352ED18-00F3-4A0B-A43C-572554D07A4FQ37885319-372B88FC-0772-4D9C-B8DC-FF504946B7FBQ37912219-245ACCED-74D8-4D35-82E8-3E15B32C6EBDQ38217119-64BC3EDC-06DE-4373-9D85-C8E5A5487F30Q38667672-CABDAB98-2F9B-4997-AFCE-74FFFEEB6A4CQ38733932-066B3948-1E16-4BA9-A200-CB701F86DFCBQ38796618-05202C24-9680-4675-A61E-8FEB9E926325Q38932102-EE11D20A-172A-4FB8-8A6C-1C86CAFB68CF
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Basics of TGF-beta and pancreatic cancer.
@en
type
label
Basics of TGF-beta and pancreatic cancer.
@en
prefLabel
Basics of TGF-beta and pancreatic cancer.
@en
P356
P1433
P1476
Basics of TGF-beta and pancreatic cancer.
@en
P2093
Mark J Truty
Raul Urrutia
P304
P356
10.1159/000108959
P577
2007-09-25T00:00:00Z